Profile
Wayne Saville worked as Vice President-Clinical Oncology at Xencor, Inc. from 2015 to 2020.
He also worked as Vice President-Clinical Development at Tocagen, Inc. Dr. Saville received his undergraduate and doctorate degrees from Northwestern University.
Former positions of Wayne Saville
| Companies | Position | End |
|---|---|---|
| XENCOR, INC. | Corporate Officer/Principal | 01/04/2020 |
| FORTE BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Training of Wayne Saville
| Northwestern University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| XENCOR, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Tocagen, Inc.
 Tocagen, Inc. BiotechnologyHealth Technology Tocagen, Inc. is a clinical-stage, cancer-selective gene therapy company, which engages in the development of product candidates designed to activate a patient's immune system against their own cancer. It is in the business of discovery, development, and commercialization of products for the treatment of cancer. The company was founded by Thomas E. Darcy, Harry E. Gruber, Douglas J. Jolly, and Dennis N. Berman in August 2007 and is headquartered San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Wayne Saville
